Regeneron Pharmaceuticals (REGN) Asset Writedowns and Impairment (2010 - 2015)
Regeneron Pharmaceuticals (REGN) posted quarterly Asset Writedowns and Impairment of $387000.0 for Q2 2015, down 92.19% year-over-year from $5.0 million in Q2 2014, and down 83.59% quarter-over-quarter from $2.4 million in Q1 2015.
Regeneron Pharmaceuticals (REGN) Asset Writedowns and Impairment (2010 - 2015) Analysis & Trends
Regeneron Pharmaceuticals' Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $387000.0 for Q2 2015.
- In Q2 2015, Asset Writedowns and Impairment fell 92.19% year-over-year to $387000.0; the TTM figure through Jun 2015 stood at $9.9 million (down 56.11% YoY), while the FY2014 annual figure was $18.1 million, down 21.72% from the prior year.
- Asset Writedowns and Impairment for Q2 2015 stood at $387000.0, down from $2.4 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $6.0 million in Q3 2013, with the low at $250000.0 in Q2 2011.
- The 4-year median for Asset Writedowns and Impairment is $4.8 million (2014), against an average of $3.5 million.
- The sharpest annual moves came in 2011 and 2015: Asset Writedowns and Impairment rose 28.39% in 2011, then tumbled 92.19% in 2015.
- Regeneron Pharmaceuticals' Asset Writedowns and Impairment stood at $1.3 million in 2011, then jumped by 345.69% to $5.7 million in 2013, then sank by 57.82% to $2.4 million in 2014, then tumbled by 84.03% to $387000.0 in 2015.
- Business Quant data shows REGN's Asset Writedowns and Impairment at $387000.0 in Q2 2015, $2.4 million in Q1 2015, and $2.4 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 387,000.00 |
| Jun 30, 2015 | 387,000.00 |
| Mar 31, 2015 | 2.36 Mn |
| Mar 31, 2015 | 2.36 Mn |
| Dec 31, 2014 | 2.42 Mn |
| Dec 31, 2014 | 2.42 Mn |
| Sep 30, 2014 | 4.76 Mn |
| Sep 30, 2014 | 4.76 Mn |
| Jun 30, 2014 | 4.96 Mn |
| Jun 30, 2014 | 4.96 Mn |
| Mar 31, 2014 | 5.92 Mn |
| Mar 31, 2014 | 5.92 Mn |
| Dec 31, 2013 | 5.75 Mn |
| Dec 31, 2013 | 5.75 Mn |
| Sep 30, 2013 | 6.00 Mn |
| Sep 30, 2013 | 6.00 Mn |
| Jun 30, 2013 | 5.53 Mn |
| Jun 30, 2013 | 5.53 Mn |
| Mar 31, 2013 | 5.78 Mn |
| Mar 31, 2013 | 5.78 Mn |